Franklin Stuart Friedman - Net Worth and Insider Trading
Franklin Stuart Friedman Net Worth
The estimated net worth of Franklin Stuart Friedman is at least $254,600 dollars as of 2024-05-20. Franklin Stuart Friedman is the Director of Deciphera Pharmaceuticals Inc and owns about 10,000 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $254,600. Details can be seen in Franklin Stuart Friedman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Franklin Stuart Friedman has not made any transactions after 2023-06-08 and currently still holds the listed stock(s).
Transaction Summary of Franklin Stuart Friedman
Franklin Stuart Friedman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Franklin Stuart Friedman owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .
Click here to see the complete history of Franklin Stuart Friedman’s form 4 insider trades.
Insider Ownership Summary of Franklin Stuart Friedman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-06-08 | director |
Franklin Stuart Friedman Latest Holdings Summary
Franklin Stuart Friedman currently owns a total of 1 stock. Franklin Stuart Friedman owns 10,000 shares of Deciphera Pharmaceuticals Inc (DCPH) as of June 8, 2023, with a value of $254,600.
Latest Holdings of Franklin Stuart Friedman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2023-06-08 | 10,000 | 25.46 | 254,600 |
Holding Weightings of Franklin Stuart Friedman
Franklin Stuart Friedman Form 4 Trading Tracker
According to the SEC Form 4 filings, Franklin Stuart Friedman has made a total of 1 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the acquisition of 10,000 shares on June 8, 2023, which cost Franklin Stuart Friedman around $138,800.
Insider Trading History of Franklin Stuart Friedman
- 1
Franklin Stuart Friedman Trading Performance
GuruFocus tracks the stock performance after each of Franklin Stuart Friedman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franklin Stuart Friedman is -0.29%. GuruFocus also compares Franklin Stuart Friedman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franklin Stuart Friedman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Franklin Stuart Friedman's insider trading performs compared to the benchmark.
Performance of Franklin Stuart Friedman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.57 |  | | | | |
| Relative Return to S&P 500(%) | -4.02 | | | | | |
Franklin Stuart Friedman Ownership Network
Franklin Stuart Friedman Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Franklin Stuart Friedman is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Franklin Stuart Friedman made 1 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net purchase of 10,000. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Franklin Stuart Friedman Mailing Address
Above is the net worth, insider trading, and ownership report for Franklin Stuart Friedman. You might contact Franklin Stuart Friedman via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
